Skip to main content
Erschienen in: Aesthetic Plastic Surgery 5/2009

01.09.2009 | Original Article

Botulinum Toxin Enhances the Implantation Effect of Adipocytes in C57/BL6 Mice

verfasst von: Min Kyung Jung, Seok Bean Song, So Young Cheon, Yoorim Park, Hyunjeong Park, Cherlhyun Kim, Byung Joo Cho, Wang Jae Lee, Jung-Wook Bang, Sa Ik Bang, Daeho Cho

Erschienen in: Aesthetic Plastic Surgery | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Recently, many plastic surgeons have been using adipogenic-differentiated cell implantation for remodeling scars in patients. However, this technique is not a long-term solution because implanted cells disappear gradually. Therefore, we investigated a method to increase the grafted cell preservation rate by using an effective adjuvant, botulinum toxin.

Methods

The adipogenic-differentiated cells were subcutaneously injected in the dorsal area of C57/BL6 mice with or without botulinum toxin. Two and six weeks later we analyzed the residual volume and confirmed the characteristics of the implanted cells by real-time RT-PCR and immunohistochemistry.

Results

Two and six weeks after transplantation we found that the residual volume of the transplantation site was higher in the botulinum toxin-treated group than in the untreated group. We also confirmed that the residual transplanted area has characteristics of adipogenic tissue by histological analysis. Next, to determine the mechanism related to the enhanced preservation rate of grafted cells via treatment with botulinum toxin, we performed immunohistochemical staining for the angiogenesis-related marker CD31. We found that CD31 expression was higher in the botulinum toxin-treated group than in the untreated group.

Conclusion

We have shown that in vivo grafted adipocyte cell preservation can be enhanced by treatment with botulinum toxin as an adjuvant. We suggest that botulinum toxin further increases this graft preservation rate by enhancing angiogenesis.
Literatur
1.
Zurück zum Zitat Ersek RA (1991) Transplantation of purified autologous fat: a 3-year follow-up is disappointing. Plast Reconstr Surg 87:219–227; discussion 228PubMed Ersek RA (1991) Transplantation of purified autologous fat: a 3-year follow-up is disappointing. Plast Reconstr Surg 87:219–227; discussion 228PubMed
2.
Zurück zum Zitat Ullmann Y, Hyams M, Ramon Y, Beach D, Peled IJ, Lindenbaum ES (1998) Enhancing the survival of aspirated human fat injected into nude mice. Plast Reconstr Surg 101:1940–1944PubMedCrossRef Ullmann Y, Hyams M, Ramon Y, Beach D, Peled IJ, Lindenbaum ES (1998) Enhancing the survival of aspirated human fat injected into nude mice. Plast Reconstr Surg 101:1940–1944PubMedCrossRef
3.
Zurück zum Zitat Cho SW, Kim SS, Rhie JW, Cho HM, Choi CY, Kim BS (2005) Engineering of volume-stable adipose tissues. Biomaterials 26:3577–3585PubMedCrossRef Cho SW, Kim SS, Rhie JW, Cho HM, Choi CY, Kim BS (2005) Engineering of volume-stable adipose tissues. Biomaterials 26:3577–3585PubMedCrossRef
4.
Zurück zum Zitat Eppley BL, Snyders RV Jr, Winkelmann T, Delfino JJ (1992) Autologous facial fat transplantation: improved graft maintenance by microbead bioactivation. J Oral Maxillofac Surg 50:477–482; discussion 482-483PubMedCrossRef Eppley BL, Snyders RV Jr, Winkelmann T, Delfino JJ (1992) Autologous facial fat transplantation: improved graft maintenance by microbead bioactivation. J Oral Maxillofac Surg 50:477–482; discussion 482-483PubMedCrossRef
5.
Zurück zum Zitat Choi YS, Park SN, Suh H (2005) Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres. Biomaterials 26:5855–5863PubMedCrossRef Choi YS, Park SN, Suh H (2005) Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres. Biomaterials 26:5855–5863PubMedCrossRef
6.
Zurück zum Zitat Hemmrich K, von Heimburg D, Rendchen R, Di Bartolo C, Milella E, Pallua N (2005) Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials 26:7025–7037PubMedCrossRef Hemmrich K, von Heimburg D, Rendchen R, Di Bartolo C, Milella E, Pallua N (2005) Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials 26:7025–7037PubMedCrossRef
7.
Zurück zum Zitat Jeon O, Ryu SH, Chung JH, Kim BS (2005) Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release 105:249–259PubMedCrossRef Jeon O, Ryu SH, Chung JH, Kim BS (2005) Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release 105:249–259PubMedCrossRef
8.
Zurück zum Zitat Kimura Y, Ozeki M, Inamoto T, Tabata Y (2003) Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24:2513–2521PubMedCrossRef Kimura Y, Ozeki M, Inamoto T, Tabata Y (2003) Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24:2513–2521PubMedCrossRef
9.
Zurück zum Zitat Ashkenazi A, Silberstein S (2008) Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol 65:146–149PubMedCrossRef Ashkenazi A, Silberstein S (2008) Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol 65:146–149PubMedCrossRef
10.
Zurück zum Zitat Lew HL, Lee EH, Castaneda A, Klima R, Date E (2008) Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil 89:75–80PubMedCrossRef Lew HL, Lee EH, Castaneda A, Klima R, Date E (2008) Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil 89:75–80PubMedCrossRef
12.
Zurück zum Zitat Beer K, Waibel J (2007) Botulinum toxin type A enhances the outcome of fractional resurfacing of the cheek. J Drugs Dermatol 6:1151–1152PubMed Beer K, Waibel J (2007) Botulinum toxin type A enhances the outcome of fractional resurfacing of the cheek. J Drugs Dermatol 6:1151–1152PubMed
13.
Zurück zum Zitat Lee H, Saladi RN, Fox JL (2008) Cohort study on patient response to botulinum toxin cosmetic therapy. J Cosmet Dermatol 7:39–42PubMedCrossRef Lee H, Saladi RN, Fox JL (2008) Cohort study on patient response to botulinum toxin cosmetic therapy. J Cosmet Dermatol 7:39–42PubMedCrossRef
14.
Zurück zum Zitat Jin R, Rummel A, Binz T, Brunger AT (2006) Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 444:1092–1095PubMedCrossRef Jin R, Rummel A, Binz T, Brunger AT (2006) Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 444:1092–1095PubMedCrossRef
15.
Zurück zum Zitat Morris JL, Jobling P, Gibbins IL (2001) Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 281:H2124–H2132PubMed Morris JL, Jobling P, Gibbins IL (2001) Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 281:H2124–H2132PubMed
16.
Zurück zum Zitat Morris JL, Jobling P, Gibbins IL (2002) Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons. Am J Physiol Heart Circ Physiol 283:H2627–H2635PubMed Morris JL, Jobling P, Gibbins IL (2002) Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons. Am J Physiol Heart Circ Physiol 283:H2627–H2635PubMed
17.
Zurück zum Zitat Tang-Liu DD, Aoki KR, Dolly JO, de Paiva A, Houchen TL, Chasseaud LF, Webber C (2003) Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon 42:461–469PubMedCrossRef Tang-Liu DD, Aoki KR, Dolly JO, de Paiva A, Houchen TL, Chasseaud LF, Webber C (2003) Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon 42:461–469PubMedCrossRef
18.
Zurück zum Zitat Christman KL, Fang Q, Yee MS, Johnson KR, Sievers RE, Lee RJ (2005) Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials 26:1139–1144PubMedCrossRef Christman KL, Fang Q, Yee MS, Johnson KR, Sievers RE, Lee RJ (2005) Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials 26:1139–1144PubMedCrossRef
19.
Zurück zum Zitat Ehrbar M, Djonov VG, Schnell C, Tschanz SA, Martiny-Baron G, Schenk U, Wood J, Burri PH, Hubbell JA, Zisch AH (2004) Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 94:1124–1132PubMedCrossRef Ehrbar M, Djonov VG, Schnell C, Tschanz SA, Martiny-Baron G, Schenk U, Wood J, Burri PH, Hubbell JA, Zisch AH (2004) Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 94:1124–1132PubMedCrossRef
20.
Zurück zum Zitat Saban MR, Towner R, Smith N, Abbott A, Neeman M, Davis CA, Simpson C, Maier J, Mémet S, Wu XR, Saban R (2007) Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer 7:219PubMedCrossRef Saban MR, Towner R, Smith N, Abbott A, Neeman M, Davis CA, Simpson C, Maier J, Mémet S, Wu XR, Saban R (2007) Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer 7:219PubMedCrossRef
21.
22.
Zurück zum Zitat Patrick CW Jr, Chauvin PB, Hobley J, Reece GP (1999) Preadipocyte seeded PLGA scaffolds for adipose tissue engineering. Tissue Eng 5:139–151PubMedCrossRef Patrick CW Jr, Chauvin PB, Hobley J, Reece GP (1999) Preadipocyte seeded PLGA scaffolds for adipose tissue engineering. Tissue Eng 5:139–151PubMedCrossRef
23.
Zurück zum Zitat Patrick CW Jr, Zheng B, Johnston C, Reece GP (2002) Long-term implantation of preadipocyte-seeded PLGA scaffolds. Tissue Eng 8:283–293PubMedCrossRef Patrick CW Jr, Zheng B, Johnston C, Reece GP (2002) Long-term implantation of preadipocyte-seeded PLGA scaffolds. Tissue Eng 8:283–293PubMedCrossRef
24.
Zurück zum Zitat Smahel J, Meyer V, Schutz K (1990) Vascular augmentation of free adipose tissue grafts. Eur J Plast Surg 13:742–748CrossRef Smahel J, Meyer V, Schutz K (1990) Vascular augmentation of free adipose tissue grafts. Eur J Plast Surg 13:742–748CrossRef
25.
Zurück zum Zitat Cho SW, Gwak SJ, Kang SW, Bhang SH, Won Song KW, Yang YS, Choi CY, Kim BS (2006) Enhancement of angiogenic efficacy of human cord blood cell transplantation. Tissue Eng 12:1651–1661PubMedCrossRef Cho SW, Gwak SJ, Kang SW, Bhang SH, Won Song KW, Yang YS, Choi CY, Kim BS (2006) Enhancement of angiogenic efficacy of human cord blood cell transplantation. Tissue Eng 12:1651–1661PubMedCrossRef
26.
Zurück zum Zitat Ansiaux R, Baudelet C, Cron GO, Segers J, Dessy C, Martinive P, De Wever J, Verrax J, Wauthier V, Beghein N, Grégoire V, Buc Calderon P, Feron O, Gallez B (2006) Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clin Cancer Res 12:1276–1283PubMedCrossRef Ansiaux R, Baudelet C, Cron GO, Segers J, Dessy C, Martinive P, De Wever J, Verrax J, Wauthier V, Beghein N, Grégoire V, Buc Calderon P, Feron O, Gallez B (2006) Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clin Cancer Res 12:1276–1283PubMedCrossRef
Metadaten
Titel
Botulinum Toxin Enhances the Implantation Effect of Adipocytes in C57/BL6 Mice
verfasst von
Min Kyung Jung
Seok Bean Song
So Young Cheon
Yoorim Park
Hyunjeong Park
Cherlhyun Kim
Byung Joo Cho
Wang Jae Lee
Jung-Wook Bang
Sa Ik Bang
Daeho Cho
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
Aesthetic Plastic Surgery / Ausgabe 5/2009
Print ISSN: 0364-216X
Elektronische ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-009-9394-0

Weitere Artikel der Ausgabe 5/2009

Aesthetic Plastic Surgery 5/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.